A neurology email list is a verified database of licensed neurologists, neurosurgeons, behavioral neurologists, and neurology subspecialists, built from conference and CME partnerships, state and national medical associations, healthcare publication networks, and B2B2C matching and verification programs. SparkDBi maintains 80,025 verified US neurology contacts across 14 subspecialties.
Trusted by Revenue and Data Teams at
SparkDBi maintains a verified neurology email list covering 80,025 neurologists, neurosurgeons, behavioral neurologists, vascular neurologists, and neurology subspecialists across the United States. Every contact is sourced from conference and CME partnerships, state and national professional associations, and healthcare publication networks, then validated through email inbox verification, phone validation, and physical address confirmation before delivery. The database refreshes monthly.
Neurology has one of the most active drug pipelines in all of pharma. Multiple sclerosis therapies, Alzheimer disease treatments, migraine biologics, epilepsy drugs, and Parkinson disease medications are all competing for neurologist attention. For device companies, deep brain stimulation, neuromonitoring, and EEG systems represent significant capital investment decisions made by a defined physician population.
Who Uses the Neurology Email List
Pharmaceutical companies with central nervous system pipelines are the primary buyer. Multiple sclerosis alone has generated more new drug approvals in the past decade than almost any other indication, with natalizumab, ocrelizumab, ofatumumab, cladribine, and siponimod all competing for neurologist prescribing decisions. Disease-modifying therapies for MS require ongoing neurologist engagement from launch through lifecycle management.
Alzheimer disease drug programs have accelerated sharply since the approval of lecanemab and the FDA review of donanemab. These programs require neurologists who can identify amyloid-positive patients, order PET imaging, and manage infusion protocols. Medical affairs and commercial teams targeting this population need verified neurologist contact data at the subspecialty level.
Migraine biologic manufacturers use the neurology list for headache specialist outreach. Erenumab, fremanezumab, galcanezumab, and eptinezumab all target a neurologist population that includes both general neurologists managing migraine and headache subspecialists at tertiary centers. CGRP antibodies and gepants have created a new competitive category with ongoing prescriber education needs.
Medical device companies manufacturing deep brain stimulators, EEG systems, EMG machines, transcranial magnetic stimulation (TMS) devices, and vagus nerve stimulators use the neurology list to reach neurologists and neurosurgeons who select, implant, or oversee these devices.
Clinical research organizations staff neurology trials for MS, Parkinson, Alzheimer, ALS, epilepsy, and migraine programs. Site identification and investigator outreach for these trials requires direct contact data for neurologists with the right subspecialty and patient volume.
Request Neurology Contact Data
Subspecialty filters, hospital affiliations, sample records available
Neurology Subspecialties and Verified Contacts
The SparkDBi neurology database covers 14 subspecialties across the neurology care team. All subspecialties are available as individual segments or combined in a master file with subspecialty flags.
| Subspecialty | Provider Type | Contacts |
|---|---|---|
| Neurologist | Physician | 18,619 |
| Neurological Surgery (Neurosurgery) | Physician | 5,242 |
| Behavioral Neurologist & Neuropsychiatrist | Physician | 5,208 |
| Clinical Neuropsychologist | Physician | 2,332 |
| Pediatrics - Neurologist | Physician | 1,134 |
| Neuromusculoskeletal Medicine & OMM | Physician | 911 |
| Vascular Neurologist | Physician | 264 |
| Chiropractor - Neurologist | Healthcare Professional | 215 |
| Physical Therapist - Neurologist | Therapist | 177 |
| Pediatrics - Neurodevelopmental Disabilities | Physician | 138 |
| Neuromuscular Medicine | Physician | 90 |
| Electroencephalography (EEG) | Technologists/Technicians | 35 |
| Electrodiagnostic Medicine | Physician | 31 |
| Neurodevelopmental Disabilities | Physician | 31 |
Key Disease Areas, Drugs and Devices
The neurological conditions that drive the most commercial outreach to the SparkDBi neurology audience are multiple sclerosis, Parkinson disease, Alzheimer disease, epilepsy, migraine, ALS, stroke, and Huntington disease.
Multiple sclerosis treatments include anti-CD20 therapies (ocrelizumab, ofatumumab), integrin antagonists (natalizumab), S1P modulators (fingolimod, siponimod, ozanimod), fumarates (dimethyl fumarate, diroximel fumarate), and oral cladribine. Each has a defined patient population and prescribing pattern that requires ongoing neurologist engagement.
Alzheimer disease entered a new treatment era with lecanemab (Leqembi) and the evolving donanemab program. These anti-amyloid antibodies require neurologist involvement in patient selection, amyloid PET or CSF testing, and ARIA monitoring. Pharma teams running these programs need neurologists with memory clinic or cognitive neurology practice backgrounds.
Epilepsy and seizure disorders continue to see new drug launches, with brivaracetam, lacosamide, perampanel, cenobamate, and fenfluramine for Dravet syndrome all active in the market. Neurologists managing refractory epilepsy patients are a targeted prescriber segment for multiple companies simultaneously.
Migraine biologics targeting CGRP (erenumab, fremanezumab, galcanezumab, eptinezumab) and CGRP receptors (rimegepant, ubrogepant, atogepant) have created significant market activity. Headache subspecialists and general neurologists managing migraine are distinct outreach targets with different prescribing patterns.
ALS treatments including riluzole, edaravone, and tofersen (Qalsody for SOD1-ALS) target a small but high-acuity neurologist population managing motor neuron disease.
NPI Taxonomy Codes for Neurology
CMS NPI taxonomy codes for reference. These are useful when specifying subspecialty requirements for a data order or verifying provider credentials independently. SparkDBi cross-references these as one of several validation inputs:
| Taxonomy Code | Neurology Classification |
|---|---|
| 2084N0400X | Neurology (General Neurologist) |
| 2084N0600X | Neurology with Special Qualification in Child Neurology |
| 2084V0102X | Vascular Neurology |
| 2084PM0002X | Neuromuscular Medicine |
| 2084B0040X | Behavioral Neurology and Neuropsychiatry |
| 2084P0301X | Brain Injury Medicine |
| 207T00000X | Neurological Surgery (Neurosurgeon) |
Practice Setting Breakdown
About 60% of neurologists in the SparkDBi database practice in hospital-based or academic medical center settings. The remaining 40% practice in private neurology groups or outpatient clinic settings. Academic neurologists at major centers tend to carry the highest clinical trial involvement and influence on prescribing patterns across affiliated community practices.
SparkDBi can filter by practice setting and by affiliation with specific neurology centers, which is useful for pharma medical affairs teams targeting opinion leaders and trial investigators.
Top 10 Hospitals for Neurology (2026 World Rankings)
The institutions that lead in neurology concentrate the highest volumes of neurologists, run the most active clinical trial programs, and set treatment protocols across affiliated networks. Rankings are from the Newsweek World's Best Specialized Hospitals 2026 report. SparkDBi maintains verified contact data for neurologists affiliated with each institution.
| Rank | Hospital | Location |
|---|---|---|
| #1 | Mayo Clinic - Rochester | Rochester, US |
| #2 | Massachusetts General Hospital | Boston, US |
| #3 | Charite - Universitatsmedizin Berlin | Berlin, DE |
| #4 | The Johns Hopkins Hospital | Baltimore, US |
| #5 | Cleveland Clinic | Cleveland, US |
| #6 | Asan Medical Center | Seoul, KR |
| #7 | AP-HP - Hopital Universitaire Pitie Salpetriere | Paris, FR |
| #8 | National Hospital For Neurology and Neurosurgery | London, UK |
| #9 | UCSF Medical Center | San Francisco, US |
| #10 | NewYork-Presbyterian Hospital - Columbia and Cornell | New York City, US |
Geographic and International Coverage
The US neurology database covers all 50 states. Highest concentrations are in California, New York, Texas, Massachusetts, and Pennsylvania, reflecting population density and the clustering of academic neurology centers in major metropolitan areas.
International neurology data is available for the UK, Germany, France, Canada, and Australia. Contact SparkDBi for current counts by country.
Deliverability and Inbox Placement
Neurologists at academic medical centers operate under enterprise email security with Proofpoint, Mimecast, or Microsoft Defender. Neurologists in private outpatient neurology groups and community practice settings face lighter filtering. SparkDBi flags enterprise hospital domains in delivered datasets so buyers can plan separate send strategies by practice type.
Data Enrichment and Available Fields
For existing neurology lists, SparkDBi can append or verify: NPI numbers, subspecialty classifications, hospital affiliations, email addresses, practice addresses, and license status. Match rates for neurology enrichment average 74% against the full database.
Compliance
The SparkDBi neurology email list contains no patient data. All records are professional contact information for licensed neurology providers. The database is HIPAA-aligned, CAN-SPAM compliant, and CCPA-aware. Business Associate Agreements are available on request.